Miniatura

Fitxers

RotroffDM.pdf (555.25 KB)

Tipus de document

Article

Versió

Versió acceptada

Data de publicació

2018-04-01

Tots els drets reservats

Si us plau utilitzeu sempre aquest identificador per citar o enllaçar aquest document: https://hdl.handle.net/2445/172753

Genetic Variants in HSD17B3, SMAD3, and IPO11 Impact Circulating Lipids in Response to Fenofibrate in Individuals With Type 2 Diabetes

Títol de la revista

Autors

Director/Tutor

ISSN de la revista

Títol del volum

Recurs relacionat

https://doi.org/10.1002/cpt.798

Resum

Individuals with type 2 diabetes (T2D) and dyslipidemia are at an increased risk of cardiovascular disease. Fibrates are a class of drugs prescribed to treat dyslipidemia, but variation in response has been observed. To evaluate common and rare genetic variants that impact lipid responses to fenofibrate in statin-treated patients with T2D, we examined lipid changes in response to fenofibrate therapy using a genomewide association study (GWAS). Associations were followed-up using gene expression studies in mice. Common variants in SMAD3 and IPO11 were marginally associated with lipid changes in black subjects (P < 5 x 10(-6)). Rare variant and gene expression changes were assessed using a false discovery rate approach. AKR7A3 and HSD17B13 were associated with lipid changes in white subjects (q < 0.2). Mice fed fenofibrate displayed reductions in Hsd17b13 gene expression (q < 0.1). Associations of variants in SMAD3, IPO11, and HSD17B13, with gene expression changes in mice indicate that transforming growth factor-beta (TGF-) and NRF2 signaling pathways may influence fenofibrate effects on dyslipidemia in patients with T2D.

Matèries

Diabetis

Matèries (anglès)

Diabetes

Citació

Col·leccions

Articles publicats en revistes (Institut d'lnvestigació Biomèdica de Bellvitge (IDIBELL))

Citació

ROTROFF, Daniel m., PIJUT, Sonja s., Skylar W., JACK, John r., HAVENER, Tammy m., PUJOL ONOFRE, Aurora, SCHLÜTER, Agatha, GRAF, Gregory a., GINSBERG, Henry n., SHAH, Hetal s., GAO, He, MORIERI, Mario-luca, DORIA, Alessandro, MYCHALECKYI, Josyf c., MCLEOD, Howard l., BUSE, John b., WAGNER, Michael j., MOTSINGER-REIF, Alison a., ACCORD/ACCORDion Investigators. Genetic Variants in HSD17B3, SMAD3, and IPO11 Impact Circulating Lipids in Response to Fenofibrate in Individuals With Type 2 Diabetes. _Clinical Pharmacology & Therapeutics_. 2018. Vol. 103, núm. 4, pàgs. 712-721. [consulta: 14 de gener de 2026]. [Disponible a: https://hdl.handle.net/2445/172753]

Exportar metadades

JSON - METS

Compartir registre